Influenza Vaccine Feasibility Study in Children With Persistent Asthma
Completed
Centers for Disease Control and Prevention
Phase 4
2016-10-10
This study is designed to note whether a larger safety study using quadrivalent live
attenuated influenza vaccine (LAIV4) versus quadrivalent inactivated influenza vaccine
(IIV4)(FLUARIX®), would be feasible in children with persistent asthma. Half of the patients
in this study will receive the FLUARIX® influenza vaccine, while the other half will receive
a cell cultured quadrivalent inactivated influenza vaccine (ccIIV4)(Flucelvax®) being used as
a surrogate for LAIV4.
Influenza Vaccine Feasibility Study in Children With Persistent Asthma
Completed
Children's Hospital Medical Center, Cincinnati
Phase 4
2016-10-10
This study is designed to note whether a larger safety study using quadrivalent live
attenuated influenza vaccine (LAIV4) versus quadrivalent inactivated influenza vaccine
(IIV4)(FLUARIX®), would be feasible in children with persistent asthma. Half of the patients
in this study will receive the FLUARIX® influenza vaccine, while the other half will receive
a cell cultured quadrivalent inactivated influenza vaccine (ccIIV4)(Flucelvax®) being used as
a surrogate for LAIV4.
Influenza Vaccine Feasibility Study in Children With Persistent Asthma
Completed
Duke University
Phase 4
2016-10-10
This study is designed to note whether a larger safety study using quadrivalent live
attenuated influenza vaccine (LAIV4) versus quadrivalent inactivated influenza vaccine
(IIV4)(FLUARIX®), would be feasible in children with persistent asthma. Half of the patients
in this study will receive the FLUARIX® influenza vaccine, while the other half will receive
a cell cultured quadrivalent inactivated influenza vaccine (ccIIV4)(Flucelvax®) being used as
a surrogate for LAIV4.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.